| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/22/2008 | US7361771 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 04/22/2008 | US7361769 Metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 04/22/2008 | US7361767 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/22/2008 | US7361765 resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine |
| 04/22/2008 | US7361755 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361663 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2261628C Process for preparing 3-pyrroline-2-carboxylic acid derivatives |
| 04/17/2008 | WO2008045671A1 Matrix metalloprotease inhibitors |
| 04/17/2008 | WO2008043567A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 04/17/2008 | WO2008011539A3 Anesthetic compounds |
| 04/17/2008 | WO2007147771A3 Tetralin and indane derivatives and uses thereof |
| 04/17/2008 | WO2007143745A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/17/2008 | WO2007085895A3 Fap inhibitors |
| 04/17/2008 | US20080091034 Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds |
| 04/17/2008 | US20080091030 Stilbene Derivatives, Light-Emitting Element, Display Device, and Electronic Device |
| 04/17/2008 | US20080090857 Statin derivatives |
| 04/17/2008 | US20080090839 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation |
| 04/17/2008 | US20080090836 Pyrazole Compounds Useful In The Treatment Of Inflammation |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1910304A2 Therapeutic agents |
| 04/16/2008 | EP1910285A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 04/16/2008 | EP1910284A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 04/16/2008 | EP1910277A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 04/16/2008 | EP1910272A1 Renin inhibitors |
| 04/16/2008 | EP1909785A2 Use of progesterone receptor modulators |
| 04/16/2008 | EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 04/16/2008 | EP1414787B1 New derivatives of substituted anilines with herbicidal activity |
| 04/16/2008 | EP1259483B1 Process for the preparation of beta-alaninamides |
| 04/16/2008 | CN101163674A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/16/2008 | CN101163673A New muscarinic receptor antagonists |
| 04/16/2008 | CN101163472A Vla-4 antagonists |
| 04/16/2008 | CN100381443C Prepn process of imide derivative |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/15/2008 | US7358398 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates |
| 04/15/2008 | US7358374 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358271 Sulpiride pharmaceutical compositions |
| 04/10/2008 | WO2008040097A1 Furanone compounds and lactam analogues thereof |
| 04/10/2008 | US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085469 Novel photoacid generators, resist compositions, and patterning process |
| 04/10/2008 | US20080083626 Ionic compound |
| 04/09/2008 | EP1907860A2 Mass labels |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907120A1 Catalyst with bimodal distribution of the particles of the catalytically active material, method for the production thereof and for the regeneration thereof and the use of the catalyst |
| 04/09/2008 | CN101160286A Process for the preparation of ccr-2 antagonist |
| 04/09/2008 | CN101157650A Method for preparation of indole-1-methyl formate and its derivatives |
| 04/09/2008 | CN101157649A 18F-Fallypride automatically synthesizing method |
| 04/09/2008 | CN101157648A Method for purifying 18F-Fallypride marker precursor compound |
| 04/09/2008 | CN100379723C Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent |
| 04/09/2008 | CN100379722C New compounds |
| 04/08/2008 | US7355053 1-phenylpyrrolidine-2-one-3-carboxamides |
| 04/08/2008 | US7354942 Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 04/08/2008 | CA2388018C Process for the preparation of amorphous atorvastatin calcium |
| 04/03/2008 | WO2008039794A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008038646A1 Process for production of 2,5-dioxopyrrolidine-3-carboxylate |
| 04/03/2008 | WO2008038637A1 Method for production of free amine |
| 04/03/2008 | WO2008038018A1 Novel minor groove binders |
| 04/03/2008 | WO2008016883A3 Inhibitors of plasma kallikrein |
| 04/03/2008 | WO2008008776A3 Hepatitis c virus inhibitors |
| 04/03/2008 | US20080081832 Imidazole derivatives, processes for preparing them and their uses |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | CA2664847A1 Novel minor groove binders |
| 04/02/2008 | EP1905759A1 N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment oftype 2 diabetes mellitus |
| 04/02/2008 | EP1904592A1 Phenylazo-acetoacetanilide derivatives with a polymer! zable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks |
| 04/02/2008 | EP1904516A2 Hepatitis c virus inhibitors |
| 04/02/2008 | EP1904442A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 04/02/2008 | EP1904441A1 Process for producing cyano substituted arene boranes and compounds |
| 04/02/2008 | EP1904439A2 Sphingosine kinase inhibitors |
| 04/02/2008 | EP1599445B1 Compounds having activity at 5ht2c receptor and uses thereof |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101155779A Production method of n-vinyl-2-pyrrolidone |
| 04/02/2008 | CN101153040A Method for synthesizing polyhydroxy pyrroline acridine alkaloid |
| 04/02/2008 | CN101153025A Pyrethroid compounds |
| 04/02/2008 | CN101153018A Br*nsted acidity ion liquid containing N-alkyl pyrrolidone group, producing method and use of the same |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/01/2008 | US7351838 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351787 Reacting polyethylene glycol with difunctional activator in presence of a tert-aminopyridine base, preferably at room temperature, and under stoichiometric conditions; activators include alkylenebis(sulfuryl halides), alkylenebis(haloformates) and nitrophenoxyalkylene-sulfuryl halides and -haloformates |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351718 Muscarinic receptor antagonists; longer duration of action; side effect reduction; high potency; chronic obstructive pulmonary disease; asthma; inhalation; 2-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide |
| 04/01/2008 | US7351717 Substituted pyrrolidine and related compounds |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | CA2446574C Liquid pharmaceutical composition |
| 03/27/2008 | WO2008035796A1 Method for producing high-purity quaternary ammonium salt |
| 03/27/2008 | WO2008004088A3 Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding |